Interpretation of Laboratory Values
Your RBC count of 5.18 ×10¹²/L and hematocrit of 46.7% are within normal limits, but your elevated RDW of 15.7% is clinically significant and warrants further investigation, as it independently predicts increased mortality risk and suggests underlying pathological processes affecting red blood cell production or survival.
Understanding Your Results
Normal Parameters
- RBC (5.18 ×10¹²/L): This falls within the normal reference range for adults
- Hematocrit (46.7%): This is normal and indicates adequate red blood cell volume
The Critical Finding: Elevated RDW
Your RDW of 15.7% exceeds the normal upper limit (typically <14.5-15%) and places you at a critical threshold. Research demonstrates that RDW >15.7% is associated with over a two-fold increase in mortality risk 1. This cutoff has been validated across multiple studies showing:
- In critically ill patients, RDW >15.8% carries a 2.61-fold increased risk of 30-day mortality 2
- The optimal cutoff of 15.75% demonstrates 71% sensitivity and 89% specificity for predicting adverse outcomes 3
- Your value sits precisely at this high-risk threshold
What Elevated RDW Indicates
An elevated RDW reflects anisocytosis (variation in red blood cell sizes) and signals underlying metabolic derangements 4:
- Inflammation and oxidative stress
- Impaired erythropoiesis (red blood cell production)
- Nutritional deficiencies (iron, folate, vitamin B12)
- Chronic disease states
- Abnormal red blood cell survival
The combination of normal RBC/hematocrit with elevated RDW suggests early pathological changes before overt anemia develops.
Required Workup
Immediate laboratory evaluation should include 5:
- Complete metabolic panel - assess kidney and liver function
- Iron studies - serum ferritin and transferrin saturation to evaluate iron stores
- Vitamin B12 and folate levels - rule out megaloblastic processes
- Reticulocyte count - assess bone marrow response
- Inflammatory markers (CRP, ESR) - identify chronic inflammation
- Peripheral blood smear - directly visualize red blood cell morphology and confirm anisocytosis 6
Critical Screening Considerations
- Gastrointestinal bleeding assessment - particularly if iron deficiency is identified 5
- Chronic kidney disease screening - check creatinine and BUN, as CKD patients develop anemia with elevated RDW 5
- Cardiovascular risk assessment - RDW predicts cardiovascular mortality 4
- Infection surveillance - elevated RDW associates with bloodstream infections (1.44-fold increased risk at your level) 2
Clinical Pitfalls to Avoid
- Do not dismiss elevated RDW as insignificant simply because hemoglobin and hematocrit are normal - RDW elevation precedes overt anemia
- Do not attribute elevated RDW solely to age - it reflects active pathology requiring investigation 4
- Hemoglobin measurement is preferred over hematocrit for ongoing monitoring due to better reproducibility 5
Prognostic Implications
The moderate discriminative power (AUC = 0.67) of RDW for mortality 2 means this is a robust independent risk factor that should trigger comprehensive evaluation rather than reassurance based on normal RBC/hematocrit alone. The fact that RDW remains significant after adjusting for multiple confounders across diverse patient populations 2, 3, 1 underscores its biological importance as a marker of systemic derangement.